Regulatory B cells (Bregs) cooperate with FOXP3⁺ regulatory T cells (Tregs) to maintain immune tolerance. Among diverse Breg subsets, IL-10⁺ Bregs are the best-defined mediators of suppression across autoimmunity and cancer. We synthesize evidence that histone deacetylases (HDACs) are the central epigenetic switch coupling cytokine and checkpoint signals to the Il10 locus, thereby programming Breg identity and stabilizing immunosuppression. Mechanistically, Blimp-1, STAT3, and c-Maf integrate environmental cues (e.g., LPS, IL-21, TIM-1 ligation) with HDAC-directed chromatin accessibility, while BACH2 and HDAC3 restrain Prdm1 to gate plasmablast-like Breg differentiation. We outline how this HDAC–IL-10 module coordinates Breg–Treg crosstalk (CD40/CD40L, PD-1/PD-L1, TIGIT, adenosinergic CD39/CD73) to suppress Th1/Th17 effectors. Disease context dictates outcome: Breg deficits fuel autoimmunity, whereas Breg expansion/reprogramming in tumors dampens cytotoxic immunity (PD-L1⁺, VISTA⁺, IL-35⁺ Bregs). We propose a framework for precision epigenetic modulation: enhancing HDAC-sensitive Breg programs to restore tolerance in autoimmunity, and disrupting tumor-skewed Breg circuits (PD-L1/VISTA, IL-35/STAT3, adenosine metabolism) to improve cancer immunotherapy. This perspective unifies Breg heterogeneity under a tractable axis—HDAC-tuned IL-10 chromatin—and highlights clinically actionable levers at the interface of epigenetics and immune regulation. IL-10-producing Bregs act in concert with Tregs to maintain immune tolerance during inflammation/promote immunosuppression during inflammation. Histone deacetylases (HDACs) tune IL-10 chromatin to set Breg state; Breg–Treg crosstalk then enforces tissue-specific tolerance or tumor immune escape. Epigenetically regulate IL-10 expression in both Bregs and Tregs. The transcriptional regulators Blimp-1, STAT3, and c-Maf integrate cytokine signaling with epigenetic control of IL-10-driven immunosuppression.
Angappulige et al. (2026) studied this question.